{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-242437","form_type":"8-K","ticker":"TCRX","cik":"0001783328","company_name":"TScan Therapeutics, Inc.","filed_at":"2022-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.019472+00:00","generated_at":"2026-06-23T11:14:38.380419+00:00","sec_items":["1.01","2.03","7.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"TScan secures up to $60M convertible debt facility with K2 HealthVentures; initial $30M tranche funds","bullets":["Loan and Security Agreement with K2 HealthVentures for up to $60M in convertible term loans.","First tranche of $30M fully funded at closing; second $10M and third $20M tranches subject to milestones and lender discretion.","Loans mature September 1, 2026; interest-only payments for 24 months (extendable to 36 on milestones), then amortize.","Interest rate is greater of 8.75% or Prime + 4.75%, capped at 9.90%; loan convertible at $4.785/share for first tranche.","Cash runway extended into Q2 2024; funds to support IND filings and solid tumor multiplexing trials."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-242437","json":"https://secwatch.observer/filing/0001193125-22-242437.json","markdown":"https://secwatch.observer/filing/0001193125-22-242437.md","text":"https://secwatch.observer/filing/0001193125-22-242437.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1783328/000119312522242437/0001193125-22-242437-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1783328/000119312522242437/d323376d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T11:14:38.380419+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}